Bull & Bear
Bull and Bear
Verdict: Avoid - real operating scale is outweighed by cash-quality, related-party, and valuation risk until deliveries fund themselves. Bull is right that Olectra is no prototype story: it has thousands of buses on road, a large pending order base, and returns that now look like a scaled industrial business. Bear wins the current debate because the same order book still runs through working-capital-heavy public-sector and affiliated channels, while the stock already prices a clean ramp. The most important tension is whether the Evey/SPV route turns into cash collections or stretched receivables. The evidence that would change the verdict is concrete: positive FY2026 free cash flow after working capital and plant capex, debtor days near 100, no increase in gross borrowings, and deliveries reaching 1,500-plus.
Bull Case
The bull scenario is a high-multiple case, roughly equivalent to 75x ₹24.7 EPS or about ₹1,850 in the existing sensitivity; it should be treated as a scenario, not a target. The required evidence is FY2026 annual results plus the Q1 FY2027 call showing 1,500-plus annual vehicle deliveries, positive free cash flow after working capital and plant capex, and debtor days still improving. The disconfirming signal is free cash flow staying negative because receivables, inventory, or payables absorb the delivery ramp, especially if debtor days move back above 180.
Bear Case
The bear scenario uses a 40x TTM EPS multiple, matching the Financials bear-case sensitivity near ₹700 if growth slows or cash conversion stays weak; it should be read as downside sensitivity, not a target. The primary evidence would be FY2026 full-year cash flow still negative or debtor days above 180. The cover signal is positive FY2026 free cash flow with debtor days near 100, no increase in gross borrowings, EV EBITDA margin at or above 10-12%, and deliveries reaching 1,500-plus.
The Real Debate
Verdict
Verdict: Avoid. Bear carries more weight because the current 73.2x P/E already assumes a cleaner backlog ramp than the evidence shows: negative FY2025 free cash flow, H1 FY2026 negative CFO, heavy related-party throughput, and repeated delivery resets. The single most important tension is cash quality through the Evey/SPV route. If 9,000 pending orders become paid deliveries, the bull case works; if they become stretched receivables, the equity owns funding risk more than scarcity. Olectra still has a real installed fleet, 29% Q3 FY2026 share, BYD continuity, and enough nameplate capacity for a higher run-rate. The condition that would change the verdict is positive FY2026 free cash flow after working capital and plant capex, debtor days around 100, gross borrowings not rising, and deliveries reaching 1,500-plus while EV margins hold at least the 10-12% long-term range. Until that proof arrives, the institutional read is that the order book is real demand but not yet investable cash earnings.
Verdict: Avoid because cash conversion and affiliated receivable risk outweigh the real backlog until FY2026 cash flow proves the ramp is self-funding.